BioCentury
ARTICLE | Company News

BioNTech, 4SC deal

February 25, 2013 8:00 AM UTC

4SC's 4SC Discovery GmbH subsidiary will identify and optimize small molecule anti-cancer drugs against undisclosed targets from BioNTech. BioNTech plans to conduct preclinical and clinical developmen...